Getting Cell therapies To IND Faster: The Advantages Of Off-The-Shelf GMP iPSCs With A DMF

As cell therapy continues to advance, the need for reliable, scalable, and regulatory-ready starting materials has never been greater. In this webinar, we explore how Applied StemCell’s off-the-shelf, GMP-grade induced pluripotent stem cell (iPSC) lines — particularly those supported by a Drug Master File (DMF) — can significantly accelerate the development of cell-based therapies. These fully characterized iPSCs are designed to streamline regulatory approval, reduce development time and cost, and support efficient gene editing and differentiation.

Backed by Applied StemCell’s patented TARGATT™ technology and a comprehensive chemistry, manufacturing, and controls (CMC) data package, these iPSC lines offer a clear and confident path from research to GMP manufacturing and commercialization.